Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Markets trade lower after RBI rate hike
Tue, 28 Jan 11:30 am

After opening firm note, the Indian indices are trading below the dotted line in the morning session after the Reserve Bank of India (RBI) hiked he benchmark repo rate by 0.25%. The buying interest is the highest in metal and auto stocks. The selling pressure is the highest in banking and software stocks.

The BSE-Sensex is trading down 40 points and the NSE-Nifty is trading down 18 points. The BSE Mid Cap index is trading up 0.2% and the BSE Small Cap index is trading up 0.3%. The rupee is trading at 62.95 to the US dollar.

Most PSU banks stocks are trading lower today. Bank of India and Canara Bank are among the stocks leading the losses. The Reserve Bank of India (RBI), in its monetary policy today has announced an interest rate hike. It has increased the benchmark lending rate, the repo rate, by 0.25% from 7.75% to 8%. It has left the cash reserve ratio (CRR) unchanged at 4%. RBI governor Raghuram Rajan has pointed to high inflation, especially consumer price inflation as the reason for this decision. However he has also stated that keeping in mind the weak economic growth environment, the RBI might reduce interest rates if inflation levels were to come down.

Most Indian pharma stocks are trading on a positive note. Dishman Pharma and Glenmark Pharma are leading among the stocks leading the gainers. As per a leading business daily, Cadila Healthcare has decided to exit its Japanese business. The company has been operating in Japan through its 100% wholly owned subsidiary. Recently, Cadila undertook a portfolio and business strategy review and the move of exiting Japanese operation was triggered after of the same. The company has been operating in Japan after it acquired 100% stake in Tokyo based Nippon Universal in 2007. It may be noted that all of the company's exports markets grew during 1HFY14 except the Japanese operation which declined by 10.3% YoY. The company's operations are spread across developed countries like US, Europe, Japan and over 25 emerging markets. Cadila Healthcare is trading higher by 0.6% today.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary


What else is happening in the markets today? Dig in...

Equitymaster requests your view! Post a comment on "Markets trade lower after RBI rate hike". Click here!

  

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 40.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 40.6% YoY). Sales on the other hand came in at Rs 38 bn (up 4.3% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2019-20 Annual Report Analysis (Annual Result Update)

Oct 26, 2020 | Updated on Oct 26, 2020

Here's an analysis of the annual report of CADILA HEALTHCARE for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

CADILA HEALTHCARE Announces Quarterly Results (1QFY21); Net Profit Up 49.3% (Quarterly Result Update)

Aug 21, 2020 | Updated on Aug 21, 2020

For the quarter ended June 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 49.3% YoY). Sales on the other hand came in at Rs 36 bn (up 4.1% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

More Views on News

Most Popular

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Worst Sector in the Market (Fast Profits Daily)

May 11, 2021

The worst sector in the stock market according to the charts.

The Key to Profit from India's EV Revolution (Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE BANKEX


May 14, 2021 03:28 PM

S&P BSE BANKEX 5-YR ANALYSIS

COMPARE COMPANY

MARKET STATS